DrugPipeline.net has announced the addition of “Global Hemoglobin Testing Market 2016-2020” research report to their website DrugPipeline.net

Bangalore, Karnataka -- (SBWire) -- 07/08/2016 --The red blood cells in the bloodstream carry a protein known as hemoglobin, which helps to transport oxygen throughout the body. Hemoglobin tests are conducted to detect the quantity of hemoglobin present in the blood. These tests are often done as a part of complete blood count during a routine health check-up or at the time of any illness to determine the type of anemia, which occurs due to low count of red blood cells.

Studies estimated that worldwide around 416 million people were living with diabetes in 2015. Out of which, around 46% of them, i.e., 191.3 million people, were not diagnosed with this disease, owing to lack of awareness. Diabetes and anemia are not directly linked, but studies reveal that around 26% of people with diabetes are diagnosed with anemia. Kidney damage or chronic kidney disease is a common condition observed in people with chronic diabetes.

Report forecast the global hemoglobin testing market to grow at a CAGR of 10.58% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global hemoglobin testing market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of hemoglobin testing equipment and consumables.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Hemoglobin Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Diagnostics
- Alere
- Danaher
- EKF Diagnostics Holdings
- Roche Diagnostics

Other prominent vendors
- ACON Laboratories
- ARKRAY
- Bayer Medical Care
- Bio-Rad Laboratories
- Daiichi Biotech
- DiaSys Diagnostic Systems
- Diazyme Laboratories
- Epinex Diagnostics
- Erba Diagnostics
- Fisher Scientific
- GREEN CROSS MEDIS
- HORIBA
- HUMAN Gesellschaft für Biochemica und Diagnostica
- Masimo
- Mindray Medical International
- OrSense
- PTS Diagnostics
- Randox Laboratories
- Sebia
- Siemens Healthcare
- Sysmex
- TaiDoc Technology
- Tosoh Bioscience
- Trinity Biotech
- Una Health

Market driver
- Development and launch of novel hemoglobin testing devices
- For a full, detailed list, view our report

Market challenge
- High cost and maintenance of hemoglobin testing
- For a full, detailed list, view our report

Market trend
- Direct-to-consumer testing
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 73 pages "Global Hemoglobin Testing Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market segmentation by product, Market segmentation by technology, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor profiles, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-hemoglobin-testing-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.